ADMA - Latest News

ADMA Biologics, Inc. (ADMA), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $2.19B. Trailing twelve-month P/E ratio is 12.79. Beta to the broader market is 0.77.

The article list below shows the most recent ADMA headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent ADMA Headlines

Bank of America Corp DE Raises Holdings in ADMA Biologics Inc $ADMA

defenseworld.net - Aug 15, 2026

Bank of America Corp DE increased its position in ADMA Biologics Inc (NASDAQ: ADMA) by 107. 5% in the undefined quarter, according to the company in i

Can Asceniv Help ADMA Stock Combat IG Market Challenges?

zacks.com - Aug 13, 2026

Asceniv drives ADMA's growth with rising adoption and real-world evidence, while competitive pressure weighs on Bivigam sales.

ADMA Biologics: The Earnings Reset Still Leaves More Upside

seekingalpha.com - Aug 12, 2026

ADMA Biologics faces a lower earnings base after some challenging times, but ASCENIV remains its key growth driver. Despite reduced long-term targets

Berger Montague PC Investigates ADMA Biologics, Inc.'s Board of Directors for Breach of Fiduciary Duty (ADMA)

newsfilecorp.com - Aug 12, 2026

Philadelphia, Pennsylvania--(Newsfile Corp. - August 12, 2026) - National plaintiffs' law firm Berger Montague PC announces an investigation into pot

ADMA Biologics, Inc. Deadline: ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

gurufocus.com - Aug 10, 2026

ADMA Biologics, Inc. Deadline: ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc.

How News Affects ADMA Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ADMA's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked ADMA news questions

What is the latest ADMA news headline?

The most recent ADMA headline (Aug 15, 2026) is "Bank of America Corp DE Raises Holdings in ADMA Biologics Inc $ADMA". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the ADMA news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What ADMA news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual ADMA options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.